Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California. more
Time Frame | AEMD | Sector | S&P500 |
---|---|---|---|
1-Week Return | 87.92% | -2.06% | -0.55% |
1-Month Return | 78.87% | -1.92% | 2.72% |
3-Month Return | 93.64% | -10.4% | 7.66% |
6-Month Return | 2.81% | -4.6% | 10.15% |
1-Year Return | -62.08% | 4.06% | 27.53% |
3-Year Return | -96.46% | 1.94% | 32.31% |
5-Year Return | -92.2% | 36.48% | 89.2% |
10-Year Return | -99.97% | 97.46% | 194.59% |
Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 650.19K | 659.10K | 294.17K | 574.25K | - | [{"date":"2020-03-31","value":98.65,"profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":44.63,"profit":true},{"date":"2023-03-31","value":87.13,"profit":true},{"date":"2024-03-31","value":"-","profit":true}] |
Cost of Revenue | 2.30B | 3.45B | 4.63B | 265.30K | 359.06K | [{"date":"2020-03-31","value":49.78,"profit":true},{"date":"2021-03-31","value":74.69,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":0.01,"profit":true},{"date":"2024-03-31","value":0.01,"profit":true}] |
Gross Profit | 650.19K | 659.10K | 294.17K | 308.94K | (359.06K) | [{"date":"2020-03-31","value":98.65,"profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":44.63,"profit":true},{"date":"2023-03-31","value":46.87,"profit":true},{"date":"2024-03-31","value":-54.48,"profit":false}] |
Gross Margin | 100.00% | 100.00% | 100.00% | 53.80% | - | [{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":53.8,"profit":true},{"date":"2024-03-31","value":"-","profit":true}] |
Operating Expenses | 6.58M | 8.55M | 10.72M | 12.62M | 12.28M | [{"date":"2020-03-31","value":52.16,"profit":true},{"date":"2021-03-31","value":67.77,"profit":true},{"date":"2022-03-31","value":84.94,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":97.32,"profit":true}] |
Operating Income | (5.93M) | (7.89M) | (10.42M) | (11.90M) | (12.64M) | [{"date":"2020-03-31","value":-592998800,"profit":false},{"date":"2021-03-31","value":-788991900,"profit":false},{"date":"2022-03-31","value":-1042088500,"profit":false},{"date":"2023-03-31","value":-1189863800,"profit":false},{"date":"2024-03-31","value":-1263656800,"profit":false}] |
Total Non-Operating Income/Expense | (504.29K) | (3.16K) | 4.79M | (120.17K) | 856.79K | [{"date":"2020-03-31","value":-10.52,"profit":false},{"date":"2021-03-31","value":-0.07,"profit":false},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":-2.51,"profit":false},{"date":"2024-03-31","value":17.87,"profit":true}] |
Pre-Tax Income | (6.38M) | (7.89M) | (10.42M) | (12.03M) | (12.21M) | [{"date":"2020-03-31","value":-638004100,"profit":false},{"date":"2021-03-31","value":-789149900,"profit":false},{"date":"2022-03-31","value":-1042088500,"profit":false},{"date":"2023-03-31","value":-1202978600,"profit":false},{"date":"2024-03-31","value":-1220817400,"profit":false}] |
Income Taxes | 48.14K | (43.15K) | (4.79K) | 131.15M | 3.00 | [{"date":"2020-03-31","value":0.04,"profit":true},{"date":"2021-03-31","value":-0.03,"profit":false},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":"-","profit":true}] |
Income After Taxes | (6.43M) | (7.85M) | (10.42M) | (143.18M) | (12.21M) | [{"date":"2020-03-31","value":-642818000,"profit":false},{"date":"2021-03-31","value":-784835000,"profit":false},{"date":"2022-03-31","value":-1041609100,"profit":false},{"date":"2023-03-31","value":-14317778600,"profit":false},{"date":"2024-03-31","value":-1220817700,"profit":false}] |
Income From Continuous Operations | (6.38M) | (7.89M) | (10.42M) | (12.03M) | (12.21M) | [{"date":"2020-03-31","value":-638004100,"profit":false},{"date":"2021-03-31","value":-789149900,"profit":false},{"date":"2022-03-31","value":-1042088500,"profit":false},{"date":"2023-03-31","value":-1202978600,"profit":false},{"date":"2024-03-31","value":-1220817400,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-03-31","value":"-","profit":true},{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] |
Net Income | (6.43M) | (7.85M) | (10.42M) | (12.03M) | (12.21M) | [{"date":"2020-03-31","value":-642818000,"profit":false},{"date":"2021-03-31","value":-784835000,"profit":false},{"date":"2022-03-31","value":-1041609100,"profit":false},{"date":"2023-03-31","value":-1202978600,"profit":false},{"date":"2024-03-31","value":-1220817400,"profit":false}] |
EPS (Diluted) | (3.16) | (0.65) | (0.71) | (0.59) | (3.64) | [{"date":"2020-03-31","value":-316,"profit":false},{"date":"2021-03-31","value":-65,"profit":false},{"date":"2022-03-31","value":-71,"profit":false},{"date":"2023-03-31","value":-59,"profit":false},{"date":"2024-03-31","value":-364,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
AEMD | |
---|---|
Cash Ratio | 2941.98 |
Current Ratio | 3061.65 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
AEMD | |
---|---|
ROA (LTM) | -50.46% |
ROE (LTM) | -105.38% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
AEMD | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 319.67 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.68 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
AEMD | |
---|---|
Trailing PE | NM |
Forward PE | 0.21 |
P/S (TTM) | 2.37 |
P/B | 0.85 |
Price/FCF | NM |
EV/R | 1.07 |
EV/Ebitda | 0.24 |
PEG | NM |
Aethlon Medical Inc (AEMD) share price today is $0.6606
Yes, Indians can buy shares of Aethlon Medical Inc (AEMD) on Vested. To buy Aethlon Medical Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AEMD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Aethlon Medical Inc (AEMD) via the Vested app. You can start investing in Aethlon Medical Inc (AEMD) with a minimum investment of $1.
You can invest in shares of Aethlon Medical Inc (AEMD) via Vested in three simple steps:
The 52-week high price of Aethlon Medical Inc (AEMD) is $2.35. The 52-week low price of Aethlon Medical Inc (AEMD) is $0.24.
The price-to-earnings (P/E) ratio of Aethlon Medical Inc (AEMD) is
The price-to-book (P/B) ratio of Aethlon Medical Inc (AEMD) is 0.85
The dividend yield of Aethlon Medical Inc (AEMD) is 0.00%
The market capitalization of Aethlon Medical Inc (AEMD) is $4.83M
The stock symbol (or ticker) of Aethlon Medical Inc is AEMD